Detailansicht

Wissensnetz

Person

Klaus Hans Metzeler (1978-)

Name	Klaus Hans Metzeler
Zeit	1978- (Lebensdaten)
Ort	Memmingen (Geburtsort) Deutschland
Variante	Klaus Metzeler (Metadaten)
Weitere Angaben	Diss. Medizinische Fakultät an der Ludwig-Maximilians-Universität München
Quelle	AM Metadaten
Datensatztyp	Person
GND-Nummer	130630810
Datensatz-ID	130630810
Beteiligt an alle anzeigen Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications – a HARMONY study Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche Prognostic impact of CEBPA mutational subgroups in adult AML Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma DNMT3A mutations in chronic myeloid leukemia Einfluss von ASXL1-Mutationen auf das Therapieansprechen bei Patienten mit chronischer myeloischer Leukämie Prognostic impact of measurable residual clonal hematopoiesis in acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation Compartment-specific mutational landscape of clonal hematopoiesis Prospective validation of a biomarker-driven response prediction model to romiplostim in lower-risk myelodysplastic neoplasms – results of the EUROPE trial by EMSCO Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia Präzisionsonkologie und molekulare Tumorboards – Konzepte, Chancen und Herausforderungen Präzisionsonkologie und molekulare Tumorboards – Konzepte, Chancen und Herausforderungen Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis Genetik der akuten myeloischen Leukämie : Bedeutung für Pathogenese, Prognose und Therapie Molecular genetic characterization of individual cancer cells isolated via single-cell printing Ein lokales GABAerges System in der Nebennierenrinde des Menschen und der Ratte Ein lokales GABAerges System in der Nebennierenrinde des Menschen und der Ratte

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Klaus Hans Metzeler (1978-)

Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications – a HARMONY study

Clonal hematopoiesis and its impact on the aging osteo-hematopoietic niche

Prognostic impact of CEBPA mutational subgroups in adult AML

Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma

DNMT3A mutations in chronic myeloid leukemia

Einfluss von ASXL1-Mutationen auf das Therapieansprechen bei Patienten mit chronischer myeloischer Leukämie

Prognostic impact of measurable residual clonal hematopoiesis in acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation

Efficacy and safety of bemcentinib in patients with advanced myelodysplastic neoplasms or acute myeloid leukemia failing hypomethylating agents- the EMSCO phase II BERGAMO trial

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification

Unsupervised meta-clustering identifies risk clusters in acute myeloid leukemia based on clinical and genetic profiles

Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy

Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome

Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification

Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation

Compartment-specific mutational landscape of clonal hematopoiesis

Prospective validation of a biomarker-driven response prediction model to romiplostim in lower-risk myelodysplastic neoplasms – results of the EUROPE trial by EMSCO

Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity

Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study

Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemia

Präzisionsonkologie und molekulare Tumorboards – Konzepte, Chancen und Herausforderungen

Präzisionsonkologie und molekulare Tumorboards – Konzepte, Chancen und Herausforderungen

Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis

Genetik der akuten myeloischen Leukämie : Bedeutung für Pathogenese, Prognose und Therapie

Molecular genetic characterization of individual cancer cells isolated via single-cell printing

Ein lokales GABAerges System in der Nebennierenrinde des Menschen und der Ratte

Ein lokales GABAerges System in der Nebennierenrinde des Menschen und der Ratte